TB-500 Frag 17-23 10mg
CAD $36.00
TB-500 Fragment 17-23 10 mg is a ≥ 99% pure TB-4–derived peptide fragment supplied as a lyophilized powder for in-vitro research applications involving cytoskeletal/actin dynamics and cell-migration assay models.
Description
TB-500 Fragment 17-23 10 mg – Actin-Modulating Research Peptide Fragment
FOR LABORATORY RESEARCH USE ONLY – NOT FOR HUMAN OR VETERINARY CONSUMPTION.
Scientific Background
TB-500 Fragment 17-23 is a short peptide fragment derived from thymosin beta-4 (TB-4) and is
under investigation in laboratory settings related to cytoskeletal dynamics. In research models, TB-4–related
sequences are commonly explored for potential interactions with actin-regulation pathways and for use in
studying cell migration, tissue remodeling signaling, and related in-vitro assay systems.
Specification
- Peptide Name: TB-500 Fragment 17-23 (TB-4 Fragment 17-23)
- Content: 10 mg lyophilized powder (requires reconstitution)
- Purity: ≥ 99% (HPLC / MS certificate available)
- Manufacturing: ISO 9001:2015 & cGMP-audited facility
- Intended Use: In-vitro laboratory research only
Storage & Handling
- Prior to reconstitution: store ≤ 8 °C in a dry environment
- After reconstitution: refrigerate 2 – 8 °C and use within 30 days
- For extended preservation: aliquot and freeze at −20 °C
- Avoid repeated freeze–thaw cycles
Previous Certificates of Analysis
Related products
